{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"PIWORLD Investor Podcasts","title":"Diaceutics (DXRX) Full Year 2022 Results presentation - April 2023","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/e4dd4355\"></iframe>","width":"100%","height":180,"duration":1832,"description":"Diaceutics CFO, Nick Roberts & CIO Ryan Keeling present full year results for the period ended 31 December 2022, which shows a strong trading performance with continued momentum driving strategic investment into 2023.\nNick Roberts, CFO00:16 - Introduction01:58 - FY22 Highlights\nNick Roberts, CFO & Ryan Keeling, CIO04:46 - Enterprise engagements06:27 - Strategy Acceleration\nNick Roberts, CFO12:26 - Revenue Growth14:33 - P&L Statement\nNick Roberts, CFO & Ryan Keeling, CIO17:06 - Growth and scale investement\nRyan Keeling, CIO21:08 - DXRX Platform28:24 - Outlook\nDiaceutics provide the world's leading pharma and life science companies with solutions and technology for the commercialisation of their precision medicines, enabled by the proprietary DXRX platform.\nDXRX is the world's first diagnostic commercialisation platform for precision medicine, utilising a global network of affiliate laboratories to deliver multiple pipelines of real-world healthcare data insights, advisory services and innovative platform enabled solutions.","thumbnail_url":"https://img.transistorcdn.com/oB5fNE4aIAia_YyTCKvE1PzrZQaD1Fjo_P7m7T9Aw_Y/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTJi/ODBiMzBmOGFhZWJi/MWEzYThkMzAyNmZm/MTdjZi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}